Menopause marks the end of the menstrual cycle, typically occurring between ages 45 and 55. It’s defined by 12 consecutive months without a period and is preceded by perimenopause, a phase of fluctuating hormones and symptoms including hot flashes, mood swings, sleep disturbances, vaginal dryness, and weight gain. These changes stem from a decline in estrogen and progesterone, two hormones that play key roles in reproductive and breast tissue health.
Age is one of the most significant risk factors for breast cancer. According to the American Cancer Society, most breast cancers are diagnosed in women over 50, which coincides with the average postmenopausal stage. It’s important to note that menopause itself does not have a direct link to developing breast cancer, but because menopause affects hormone levels, it may factor into your risk level:
Understanding this link helps women assess risk based on their personal and family history.
Regular screening with a mammogram is the best tool physicians have for detecting breast cancer as early as possible. For women with an average risk of developing breast cancer, screening recommendations are:
Some women with a higher risk level may be recommended to start screening earlier or have additional screening. Talk to your healthcare provider about the screening options best for you.
Hormone replacement therapy (HRT) is a hormonal treatment that is often prescribed to alleviate menopausal symptoms, like hot flashes, night sweats, and vaginal dryness. Because this medication directly affects hormone levels, there are several factors to consider when it comes to breast cancer risk.
Studies have shown:
Talk to your physician about your risk level and your options to make an informed decision that best fits your health needs.
Breast cancer treatments can significantly affect hormonal balance, often triggering menopause earlier than expected or intensifying its symptoms. This treatment-induced menopause can be temporary or permanent, depending on the type and duration of therapy.
Chemotherapy
Chemotherapy targets rapidly dividing cells, including those in the ovaries. This can lead to:
Hormone Therapy
Many breast cancers are hormone receptor-positive, meaning they grow in response to estrogen or progesterone. To reduce recurrence risk, hormone therapies are used to block or suppress these hormones:
Surgical Menopause
In some patients with a high risk of breast cancer recurrence, the ovaries may be surgically removed. This causes immediate, permanent menopause.
Symptoms like hot flashes, mood swings, and fatigue may appear suddenly and feel more intense in treatment-induced menopause than in natural menopause due to the abrupt hormonal drop. Some patients may also experience feelings of anxiety or depression.
There are several ways to manage menopausal symptoms:
Talk to your physician if you have any concerns about your menopausal symptoms during chemotherapy.
September 2025